Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn's disease and
ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise …

Distinction between Crohn's disease of the colon-rectum and ulcerative colitis or
inflammatory bowel disease (IBD) type unclassified can be of pivotal importance for a …

Serologic biomarkers for inflammatory bowel disease (IBD) have yielded variable
differentiating ability. Quantitative analysis of a large number of metabolites is a promising …

Inflammatory bowel disease (IBD) is a chronic, complex relapsing disorder characterised by
immune dysregulation, gut microbiota alteration, and disturbed intestinal permeability. The …

The enteric bacterial flora play a key role in maintaining health. Inflammatory bowel disease
is associated with quantitative and qualitative alterations in the microbiota. Early …

The aetiopathogenesis of inflammatory bowel diseases (IBD) involves the complex
interaction between a patient's genetic predisposition, environment, gut microbiota and …

Inflammatory bowel disease (IBD), including ulcerative colitis, Crohn's disease, and
unclassified IBD, continues to cause significant morbidity. While its incidence is increasing …

Metabolomics is recognized as a powerful top‐down system biological approach to
understand genetic‐environment‐health paradigms paving new avenues to identify …

Despite the increasing use of protoplasts in plant biotechnology research, shoot
regeneration from protoplasts remains challenging. In this study, we investigated the factors …

Ulcerative colitis (UC) is a relapsing inflammatory disease of unknown etiology. The
increased risk of cancer in UC patients warrants for the development of novel drug …